We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
246 hedge funds and large institutions have $3.44B invested in Acadia Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 69 increasing their positions, 94 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
435% more call options, than puts
Call options by funds: $87.4M | Put options by funds: $16.3M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
45% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 29
43% more capital invested
Capital invested by funds: $2.4B → $3.44B (+$1.03B)
4% more funds holding
Funds holding: 236 → 246 (+10)
2.02% more ownership
Funds ownership: 90.16% → 92.19% (+2%)
27% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 94
Holders
246
Holders Change
+10
Holders Change %
+4.24%
% of All Funds
3.79%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
42
Increased
69
Reduced
94
Closed
29
Calls
$87.4M
Puts
$16.3M
Net Calls
+$71.1M
Net Calls Change
+$57.3M
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$61.6M |
| 2 |
PA
Perceptive Advisors
New York
|
+$31.9M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$15.1M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$14.4M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$14.2M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$40.9M |
| 2 |
D.E. Shaw & Co
New York
|
-$21M |
| 3 |
State Street
Boston,
Massachusetts
|
-$18.3M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$11M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$8.93M |
